Although androgenic signaling represents the primary stimuli for prostatic proliferation and BPH development, several lines of evidence suggested the implication of estrogen action via its distinct receptors; estrogen receptor-α (ER-α) and estrogen receptor-β (ER-β)2. The gene discussed is ESR1; the disease is benign prostatic hyperplasia.